Cargando…

Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples

Large-scale molecular profiling technologies have assisted the identification of disease biomarkers and facilitated the basic understanding of cellular processes. However, samples collected from human subjects in clinical trials possess a level of complexity, arising from multiple cell types, that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Ting, Hartmann, Nicole, Kohane, Isaac S., Brinkmann, Volker, Staedtler, Frank, Letzkus, Martin, Bongiovanni, Sandrine, Szustakowski, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217948/
https://www.ncbi.nlm.nih.gov/pubmed/22110609
http://dx.doi.org/10.1371/journal.pone.0027156
_version_ 1782216638578294784
author Gong, Ting
Hartmann, Nicole
Kohane, Isaac S.
Brinkmann, Volker
Staedtler, Frank
Letzkus, Martin
Bongiovanni, Sandrine
Szustakowski, Joseph D.
author_facet Gong, Ting
Hartmann, Nicole
Kohane, Isaac S.
Brinkmann, Volker
Staedtler, Frank
Letzkus, Martin
Bongiovanni, Sandrine
Szustakowski, Joseph D.
author_sort Gong, Ting
collection PubMed
description Large-scale molecular profiling technologies have assisted the identification of disease biomarkers and facilitated the basic understanding of cellular processes. However, samples collected from human subjects in clinical trials possess a level of complexity, arising from multiple cell types, that can obfuscate the analysis of data derived from them. Failure to identify, quantify, and incorporate sources of heterogeneity into an analysis can have widespread and detrimental effects on subsequent statistical studies. We describe an approach that builds upon a linear latent variable model, in which expression levels from mixed cell populations are modeled as the weighted average of expression from different cell types. We solve these equations using quadratic programming, which efficiently identifies the globally optimal solution while preserving non-negativity of the fraction of the cells. We applied our method to various existing platforms to estimate proportions of different pure cell or tissue types and gene expression profilings of distinct phenotypes, with a focus on complex samples collected in clinical trials. We tested our methods on several well controlled benchmark data sets with known mixing fractions of pure cell or tissue types and mRNA expression profiling data from samples collected in a clinical trial. Accurate agreement between predicted and actual mixing fractions was observed. In addition, our method was able to predict mixing fractions for more than ten species of circulating cells and to provide accurate estimates for relatively rare cell types (<10% total population). Furthermore, accurate changes in leukocyte trafficking associated with Fingolomid (FTY720) treatment were identified that were consistent with previous results generated by both cell counts and flow cytometry. These data suggest that our method can solve one of the open questions regarding the analysis of complex transcriptional data: namely, how to identify the optimal mixing fractions in a given experiment.
format Online
Article
Text
id pubmed-3217948
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32179482011-11-21 Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples Gong, Ting Hartmann, Nicole Kohane, Isaac S. Brinkmann, Volker Staedtler, Frank Letzkus, Martin Bongiovanni, Sandrine Szustakowski, Joseph D. PLoS One Research Article Large-scale molecular profiling technologies have assisted the identification of disease biomarkers and facilitated the basic understanding of cellular processes. However, samples collected from human subjects in clinical trials possess a level of complexity, arising from multiple cell types, that can obfuscate the analysis of data derived from them. Failure to identify, quantify, and incorporate sources of heterogeneity into an analysis can have widespread and detrimental effects on subsequent statistical studies. We describe an approach that builds upon a linear latent variable model, in which expression levels from mixed cell populations are modeled as the weighted average of expression from different cell types. We solve these equations using quadratic programming, which efficiently identifies the globally optimal solution while preserving non-negativity of the fraction of the cells. We applied our method to various existing platforms to estimate proportions of different pure cell or tissue types and gene expression profilings of distinct phenotypes, with a focus on complex samples collected in clinical trials. We tested our methods on several well controlled benchmark data sets with known mixing fractions of pure cell or tissue types and mRNA expression profiling data from samples collected in a clinical trial. Accurate agreement between predicted and actual mixing fractions was observed. In addition, our method was able to predict mixing fractions for more than ten species of circulating cells and to provide accurate estimates for relatively rare cell types (<10% total population). Furthermore, accurate changes in leukocyte trafficking associated with Fingolomid (FTY720) treatment were identified that were consistent with previous results generated by both cell counts and flow cytometry. These data suggest that our method can solve one of the open questions regarding the analysis of complex transcriptional data: namely, how to identify the optimal mixing fractions in a given experiment. Public Library of Science 2011-11-16 /pmc/articles/PMC3217948/ /pubmed/22110609 http://dx.doi.org/10.1371/journal.pone.0027156 Text en Gong et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gong, Ting
Hartmann, Nicole
Kohane, Isaac S.
Brinkmann, Volker
Staedtler, Frank
Letzkus, Martin
Bongiovanni, Sandrine
Szustakowski, Joseph D.
Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title_full Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title_fullStr Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title_full_unstemmed Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title_short Optimal Deconvolution of Transcriptional Profiling Data Using Quadratic Programming with Application to Complex Clinical Blood Samples
title_sort optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samples
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217948/
https://www.ncbi.nlm.nih.gov/pubmed/22110609
http://dx.doi.org/10.1371/journal.pone.0027156
work_keys_str_mv AT gongting optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT hartmannnicole optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT kohaneisaacs optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT brinkmannvolker optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT staedtlerfrank optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT letzkusmartin optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT bongiovannisandrine optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples
AT szustakowskijosephd optimaldeconvolutionoftranscriptionalprofilingdatausingquadraticprogrammingwithapplicationtocomplexclinicalbloodsamples